Summary
Signal counts
Assets tracked: 2
Watchlist assets: 2
Registry stop assets: 0
Sponsor overview
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Public clinical-program risk signals across linked oncology Phase 2 assets for this sponsor.
Evidence links
Public sources
https://clinicaltrials.gov/study/NCT01973322 | https://clinicaltrials.gov/study/NCT04523688
Assets
Linked programs
- arm 1: DC Vaccine + RT: Results Not Found Signal (3/5)
- Autologous Dendritic Cells (DC) vaccine: Timeline Staleness Signal (3/5)